Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

05 Aug 2022
0
0

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

Tags

Share this

Related Posts

Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients. Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D*, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S. Blood Cells Mol Dis. 2007 Nov-Dec;39(3):348-52.
01 Nov 2007
0

Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients. Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D*, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S. Blood Cells Mol Dis. 2007 Nov-Dec;39(3):348-52.

Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients. Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D*, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S. Blood Cells Mol Dis. 2007 Nov-Dec;39(3):348-52.
View More

Recent Posts